Beijert, IJ, Hentschel, AE, Brundl, J, Comperat, EM, Plass, K, Rodriguez, O, Henriquez, JDS, Henraquez, V, de la Pena, E, Alemany, I, Turturica, D, Pisano, F, Soria, F, Capoun, O, Bauerova, L, Pesl, M, Bruins, HM, Runneboom, W, Herdegen, S, Breyer, J, Brisuda, A, Calatrava, A, Rubio-Briones, J, Seles, M, Mannweiler, S, Bosschieter, J, Kusuma, VRM, Ashabere, D, Huebner, N, Cotte, J, Mertens, LS, Claps, F, Masson-Lecomte, A, Liedberg, F, Cohen, D, Lunelli, L, Cussenot, O, El Sheikh, S, Volanis, D, Cote, JF, Roupret, M, Haitel, A, Shariat, SF, Mostafid, AH, Nieuwenhuijzen, JA, Zigeuner, R, Dominguez-Escrig, JL, Hacek, J, Zlotta, AR, Zigeuner, M, Evert, M, Hulsbergen-van de Kaa, CA, van der Heijden, AG, Kiemeney, LALM, Soukup, V, Molinaro, L, Gontero, P, Llorente, C, Algaba, F, Palou, J, N'Dow, J, Ribal, MJ, van der Kwast, TH, Babjuk, M, Sylvester, RJ, van Rhijn, BWG. Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum. European Urology Oncology. 2023; 6(2)DOI:10.1016/j.euo.2023.01.004. PMID:36670042. IF:8.300(Q1/1D).

Checcucci, E, Verri, P, Amparore, D, Cacciamani, GE, Fiori, C, Breda, A, Porpiglia, F. Generative Pre-training Transformer Chat (ChatGPT) in the scientific community: the train has left the station. Minerva Urology And Nephrology. 2023; 75(2)DOI:10.23736/S2724-6051.23.05326-0. PMID:36883768. IF:4.900(Q1/2D).

Territo, A, Baboudjian, M, Diana, P, Gallioli, A, Verri, P, Uleri, A, Basile, G, Tedde, A, Gaya, JM, Huguet, J, Rodriguez-Faba, O, Sanguedolce, F, Gomez, IS, Molina, RS, Palou, J, Breda, A. To drain or not to drain in uro-oncological robotic surgery? A systematic review and meta-analysis. Minerva Urology And Nephrology. 2023; 75(2)DOI:10.23736/S2724-6051.22.05160-6. PMID:36722161. IF:4.900(Q1/2D).

Bonet, M, Gonzalez, D, Baquedano, JE, Garcia, E, Altabas, M, Casas, F, Feltes, N, Ferrer, F, Foro, P, Fuentes, R, Galdeano, M, Gomez, D, Henriquez, I, Jove, J, Lozano, J, Maldonado, X, Mases, J, Membrive, I, Paredes, S, Rosello, A, Sancho, G, Mira, M. Management of high-risk and post-operative non-metastatic prostate cancer in Catalonia: an expert Delphi consensus. Clinical & Translational Oncology. 2023; 25(4)DOI:10.1007/s12094-022-03005-4. PMID:36436177. IF:2.800(Q2/5D).